Sources | Names Used |
---|---|
GDSC1000 | KIN001-244 |
PharmacoGx | KIN001-244 |
Database | Identifier |
---|---|
Smiles: | Fc1ccc(Cn2cccc(C(=O)N[C@@H](COc3ccc4[nH]c(=O)[nH]c4c3)c3ccccc3)c2=O)cc1F |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CYP19A1 | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-06 |
mRNA | ANXA7 | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
mRNA | PHLDA1 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |
mRNA | SLC35D2 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0005 |
mRNA | LSP1 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0002 |
mRNA | CYR61 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0009 |
mRNA | IRF5 | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
mRNA | CTTN | GDSC1000 | pan-cancer | AAC | -0.14 | 0.005 |
mRNA | IL2RA | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-06 |
mRNA | PPARG | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |